Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2010
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811790 Polymyxin synthetase and gene cluster thereof
10/12/2010US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents
10/12/2010US7811788 novel haplotype of the human taste receptor hT2R50 in the T2R taste receptor family that responds to particular bitter ligands, i.e., 2-acetylpyrazine and ethylpyrazine; used as additives in foods, beverages and medicinals for modifying (blocking) hT2R50-associated bitter taste
10/12/2010US7811787 targets for therapeutic intervention in immunological and inflammatory disorders, autoimmune , pulmonary , proliferative immune disorders, and cancer; involved in the negative regulation of intracellular T-cell signal transduction
10/12/2010US7811786 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor
10/12/2010US7811785 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
10/12/2010US7811777 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer
10/12/2010US7811769 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
10/12/2010US7811760 Vector and method for detecting the change in transcription amount
10/12/2010US7811758 Using apparatus comprising adsorbent solid phase to recover nucleotide sequences from specimen fluids; DNA recovery
10/12/2010US7811757 Using shed cellular material as evaluative indicator of cell proliferative disorders
10/12/2010US7811754 plurality of wildtype and SNP probes are immobilized on a planar waveguide, a fluorescently labeled analyte is then flowed over the planar waveguide, binding of the analyte to the wildtype and SNP probes is detected in real-time and the hybridization kinetics are compared
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811585 Streptococcus pyogenes antigens
10/12/2010US7811582 Herpes viruses for immune modulation
10/12/2010US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
10/12/2010US7811579 Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
10/12/2010US7811576 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811569 Recombinant anti-Plasmodium falciparum antibodies
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010US7811559 Administering to the patient an amount of CLN2 protein (Neuronal ceroid lipofuscinoses (NCLs)) effective to reduce or eliminate the symptoms caused by the deficiencyl in CLN2 protein; Central nervous system disorders
10/12/2010CA2497818C Glyt1 transgenic mice
10/12/2010CA2497287C Method of humanizing immune system molecules
10/12/2010CA2422752C Map-based genome mining method for identifying regulatory loci controlling the level of gene transcripts and products
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2375224C Human antithrombin variants
10/12/2010CA2367468C Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
10/12/2010CA2358992C Method for controlling the extension of an oligonucleotide
10/12/2010CA2341268C Streptococcus suis vaccines and diagnostic tests
10/12/2010CA2339034C Process for purifying human papillomavirus virus-like particles
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/12/2010CA2336114C Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
10/12/2010CA2328058C Dsrna-mediated regulation of gene expression in plants
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2307065C Modulating robo:ligand interactions
10/12/2010CA2285221C Improvements relating to the specificity of gene expression
10/12/2010CA2282793C Non-invasive prenatal diagnosis
10/12/2010CA2276233C Compositions and methods for modulating gene expression in plants
10/12/2010CA2270023C Improved methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues
10/12/2010CA2245494C Human c-ha-ras proto-oncogene transgenic rat
10/12/2010CA2230925C Fusion protein delivery system and uses thereof
10/12/2010CA2219943C Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
10/12/2010CA2196570C Recombinant herpesvirus of turkeys and uses thereof
10/12/2010CA2151547C Recombinant chimeric proteins and methods of use thereof
10/09/2010CA2701013A1 Markers associated with resistance to aphis glycines and methods of use therefor
10/07/2010WO2010115210A2 Mouse models
10/07/2010WO2010115207A1 Chimeras between gpc-receptors and binding partners thereof
10/07/2010WO2010115133A2 Newcastle disease virus vectored avian vaccines
10/07/2010WO2010115119A2 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents
10/07/2010WO2010115115A1 Dendritic cell-boosted humanized immune system mice
10/07/2010WO2010115067A2 Engineering the pathway for succinate production
10/07/2010WO2010115052A2 Induced pluripotent stem cells
10/07/2010WO2010115050A2 Embryonic stem cell specific micrornas promote induced pluripotency
10/07/2010WO2010115044A2 Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation
10/07/2010WO2010115016A2 Nucleic acid preparation compositions and methods
10/07/2010WO2010114989A1 Use of a seed specific promoter to drive odp1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination
10/07/2010WO2010114979A2 Radiation therapy biomarkers
10/07/2010WO2010114948A2 An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors
10/07/2010WO2010114940A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010WO2010114860A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010WO2010114615A2 A facile system for encoding unnatural amino acids in mammalian cells
10/07/2010WO2010114395A1 Control of gene expression in plants using a perennial ryegrass (lolium perenne l.) derived promoter
10/07/2010WO2010114270A2 Method for selecting a high expression recombinant cell line
10/07/2010WO2010114245A2 Microorganisms of corynebacterium with improved 5'-inosinic acid productivity, and method for producing nucleic acids using same
10/07/2010WO2010114143A1 System for increasing activity of specific promoter, and vector carrying the system
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114024A1 Method for promoting the formation of secondary cell wall of plant
10/07/2010WO2010114013A1 Polyion complex of double-stranded ribonucleic acid
10/07/2010WO2010113988A1 Method for producing anti-gpcr antibody and anti-gpcr antibody
10/07/2010WO2010113844A1 Rnai molecule for thymidylate synthase and use thereof
10/07/2010WO2010113832A1 Coryneform bacterium transformant, and process for producing isobutanol using same
10/07/2010WO2010113789A1 Method for designing primer for selex method, method for producing primer, method for producing aptamer, device for designing primer, and computer program and recording medium for designing primer
10/07/2010WO2010113647A1 Vector utilizing borna disease virus and use thereof
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
10/07/2010WO2010113529A1 Method for detection of colorectal tumor
10/07/2010WO2010113507A1 Double-stranded molecule inhibiting the expression of gpc3
10/07/2010WO2010113497A1 Method for culturing microorganism, and process for producing substance with microorganism
10/07/2010WO2010113495A1 C6orf167 peptides and vaccines containing the same
10/07/2010WO2010113452A1 Method of distinguishing genotypes
10/07/2010WO2010113172A1 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
10/07/2010WO2010113149A1 Compositions and methods for increasing oil content in algae
10/07/2010WO2010113132A1 Use of inhibitors of st3gal6 activity for modulation of adipogenesis
10/07/2010WO2010113039A1 Mutants of activation-induced cytidine deaminase (aid) and methods of use
10/07/2010WO2010113037A1 Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements
10/07/2010WO2010113031A2 Method of altering nucleic acids
10/07/2010WO2010113020A1 An enzyme with alpha-glucuronidase activity
10/07/2010WO2010112935A1 Diagnostic test for virus
10/07/2010WO2010112842A2 Anti viral therapy
10/07/2010WO2010112840A1 A method for in vitro molecular evolution of protein function
10/07/2010WO2010112821A1 Genotoxicity testing
10/07/2010WO2010112533A1 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
10/07/2010WO2010112034A2 Compositions and methods for treatment and diagnosis of synucleinopathies
10/07/2010WO2010111891A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 4023